Valuation dashboard for Nyxoah S.A. (NYXH) with P/E N/A, P/B 0.88, EV/EBITDA -1.59 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Analysis Summary
Nyxoah S.A. reported revenue of $10.0M in the most recent fiscal year, growing at a 5-year CAGR of 170.6%.
Trailing-twelve-month margins: gross margin 51.3%, operating margin -383.1%, net margin -434.7%.
At the current price of $1.49, NYXH has negative trailing earnings (P/E not meaningful) and an ROE of -179.71%. Market capitalisation stands at $149M.
Balance sheet quality for NYXH: current ratio of 1.3. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.88 |
| EV / EBITDA | -1.59 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-75.23 |
| vs Current Price | -5149.0% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| NYXH | Nyxoah S.A. | $149M | 0.88 | -179.7% | |
| ALC | Alcon Inc. | $31.8B | 51.18 | 1.50 | |
| 0A0D.L | Alcon Inc. | $27.0B | |||
| STE | STERIS plc | $20.3B | |||
| 0JZ2.L | Masimo Corporation | $9.5B | 9.69 | -21.0% | |
| 0QLQ.L | Ypsomed Holding AG | $4.7B | |||
| 0A05.L | Medacta Group S.A. | $2.2B |
Price
| Price | $1.49 |
| Market Cap | $149M |
| Exchange | NASDAQ |
| Country | BE |
Profitability
| Return on Equity | -179.71% |
| Return on Invested Capital | -59.89% |
| Return on Assets | -58.46% |
| Gross Margin | 51.31% |
| Operating Margin | -383.05% |
| Net Margin | -434.72% |
Related companies: CATX · GNFT · IVVD · KRMD · OABI · OSUR · PRE
Explore sector: Healthcare · Medical - Specialties
More sections of NYXH: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks